Strategic Market Access, Key Opinion Leader (KOL) Engagement, and Accelerated Commercialization Specialized in Gastroenterology & GI Health.
Unlocking South Korea's High-Growth GI Market
South Korea represents one of the most dynamic, high-volume healthcare markets for gastroenterology innovation in Asia.
Over the past decade, Inflammatory Bowel Disease (Crohn’s Disease & Ulcerative Colitis) prevalence in South Korea has more than doubled, surpassing 80,000+ registered patients due to Westernized lifestyle shifts.
Backed by South Korea’s National Cancer Screening Program, millions of screening and therapeutic endoscopies are conducted annually, driving sustained demand for advanced diagnostic and therapeutic devices.
Top-tier university hospital GI centers in South Korea offer world-class clinical efficiency and eager technology adoption by leading global Key Opinion Leaders (KOLs).
Combining 30+ years of collective healthcare commercialization expertise anchored in Vancouver and Seoul.
Founding Partner
Specialized in cross-border MedTech commercialization, market access strategy, and corporate development connecting North America with Asia.
Grounded in rigorous quantitative analysis from UNC Chapel Hill (Mathematics & Statistics), Minwoo orchestrates strategic alignment between foreign device manufacturers and premier Korean gastroenterology centers.
Co-Founder
A seasoned healthcare industry leader with over two decades of comprehensive experience spanning pharmaceutical and medical device sectors in South Korea.
Seojin possesses a deep track record across Sales & Marketing, Market Access, Regulatory Affairs, and Reimbursement Strategy, ensuring seamless market entry and rapid clinical adoption in top-tier hospital systems.
End-to-End Market Access Solutions
Navigating South Korea's Ministry of Food and Drug Safety (MFDS) approval pathways and HIRA health insurance reimbursement strategy with precision.
Connecting innovative MedTech products directly with premier gastroenterology professors and clinical testing centers to accelerate adoption.
Establishing vetted local distribution networks and commercial execution plans to secure sustainable long-term market presence.
Partner with VanKor MedTech Solutions to accelerate market access and build trusted clinical relationships in Asia.
Scan QR code to connect directly with Minwoo Lee on LinkedIn
Open LinkedIn Profile →